AHKCU

Prime Time BioLabs supplies AHKCU 50 mg as a research-grade quantity of AHK-Cu peptide, the copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine (Ala-His-Lys), also referred to as Copper Tripeptide-3. Each vial contains a sterile lyophilized powder, supplied at a nominal 50 mg quantity in a light-protected vial labeled with its lot number for traceability. A batch-matched Certificate of Analysis is available for download, and reconstitution and storage guidance ships with every order.

AHK-Cu is a copper-binding tripeptide structurally related to GHK-Cu, with alanine in place of glycine at the N-terminus. Ex vivo and in vitro research has examined AHK-Cu's effects on dermal fibroblast and dermal papilla cell activity, including stimulation of human hair-follicle elongation and dermal papilla cell proliferation at low concentrations in organ-culture and cell-culture models. Researchers have also studied its comparative stability and receptor-binding characteristics relative to GHK-Cu. This evidence is concentrated in cell-based and ex vivo models; robust peer-reviewed human clinical data specific to AHK-Cu is limited. AHK-Cu's structural relationship to GHK-Cu does not mean GHK-Cu's more extensive research findings — including its human and animal wound-healing literature — apply to AHK-Cu; the two compounds are studied separately, and evidence should not be transferred between them.

AHKCU 50 mg is manufactured under quality controls and independently verified via HPLC and mass spectrometry before release. HPLC establishes relative purity — the target compound's proportion against detected impurities — while mass spectrometry confirms molecular identity by matching measured mass against the expected value. Together, these two methods establish that a vial's contents match their published purity and identity profile; neither test speaks to safety, efficacy, or suitability for any use outside laboratory research. Each batch ships with a Certificate of Analysis showing the batch number, purity result, and analysis date, so results can be traced to the specific vial in hand. Purity and identity testing confirm what a compound is and how pure it is — they do not constitute clinical validation, FDA approval, or evidence of any biological effect in humans or animals.

This product is intended for in-vitro laboratory research only. AHKCU 50 mg is not approved for human or veterinary use, has not been reviewed by the FDA, and must not be used as a food, drug, or cosmetic. It is not intended for diagnostic or therapeutic use of any kind and should be handled only by qualified researchers in a laboratory setting.